Precipio Inc (PRPO)

Currency in USD
13.900
-0.296(-2.09%)
Closed·
PRPO Scorecard
Full Analysis
Net income is expected to grow this year
PRPO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.80014.049
52 wk Range
3.90016.890
Key Statistics
Prev. Close
14.196
Open
13.901
Day's Range
13.8-14.049
52 wk Range
3.9-16.89
Volume
2.62K
Average Volume (3m)
11.47K
1-Year Change
162.26%
Book Value / Share
7.78
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PRPO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Precipio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Precipio Inc Company Profile

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Precipio Inc Earnings Call Summary for Q1/2025

  • Revenue up 43% YoY to $4.9M in Q1 2025; gross margins improved from 27% to 43%
  • Stock surged 8.39% in aftermarket trading; company appears undervalued per InvestingPro analysis
  • Adjusted EBITDA improved 92% YoY; net cash usage down 49% YoY
  • Positive cash flow expected by Q2/Q3 2025; revenue growth forecast at 2.5x for FY 2025
  • CEO highlights strong pathology business, product pipeline, and balance sheet; analysts maintain Strong Buy consensus
Last Updated: 15/05/2025, 22:40
Read Full Transcript

Compare PRPO to Peers and Sector

Metrics to compare
PRPO
Peers
Sector
Relationship
P/E Ratio
−6.8x−0.1x−0.5x
PEG Ratio
−0.160.010.00
Price/Book
1.8x0.8x2.6x
Price / LTM Sales
1.1x1.1x3.3x
Upside (Analyst Target)
-41.5%43.5%
Fair Value Upside
Unlock9.0%6.8%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.59 / --
Revenue / Forecast
4.93M / --
EPS Revisions
Last 90 days

PRPO Income Statement

People Also Watch

18.23
SRPT
+1.50%
120.41
CRDO
+0.53%
0.984
GAME
+1.76%
9.070
CAPR
+12.39%
0.90
KLTO
-4.25%

FAQ

What Stock Exchange Does Precipio Trade On?

Precipio is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Precipio?

The stock symbol for Precipio is "PRPO."

What Is the Precipio Market Cap?

As of today, Precipio market cap is 21.08M.

What Is Precipio's Earnings Per Share (TTM)?

The Precipio EPS (TTM) is -2.08.

From a Technical Analysis Perspective, Is PRPO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Precipio Stock Split?

Precipio has split 4 times.

How Many Employees Does Precipio Have?

Precipio has 57 employees.

What is the current trading status of Precipio (PRPO)?

As of 09 Aug 2025, Precipio (PRPO) is trading at a price of 13.90, with a previous close of 14.20. The stock has fluctuated within a day range of 13.80 to 14.05, while its 52-week range spans from 3.90 to 16.89.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.